(Q46456979)

English

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme

scientific article published in January 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

0 references

Mira Harrison-Woolrych

1

object named as

Mira Harrison-Woolrych

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

object named as

Peter Herbison

2

0 references

object named as

Rachael McLean

3

0 references

4

object named as

Janelle Ashton

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

author name string

Jim Slattery

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

28

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

435-442

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arthritis medicines and cardiovascular events--"house of coxibs".

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The New Zealand intensive medicines monitoring programme in pro-active safety surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Merck withdraws arthritis drug worldwide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200528050-00006

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15853444

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46456979&oldid=2233504985"